Claims
- 1. A pharmacologically acceptable salt of isovaleryl L-carnitine 11-hydroxyundecyl ester.
- 2. A pharmacologically acceptable salt of isovaleryl L-carnitine 10-hydroxydecyl ester.
- 3. A pharmaceutical composition, comprising an amount of an ester of claim 1 effective for the treatment of endotoxic shock, and a pharmacologically acceptable excipient.
- 4. A pharmaceutical composition, comprising an amount of an ester of claim 2 effective for the treatment of endotoxic shock, and a pharmacologically acceptable excipient.
- 5. A method of treating endotoxic shock comprising administering an effective amount of the pharmacologically acceptable salt of claim 1 to a patient in need thereof.
- 6. A method of treating endotoxic shock comprising administering an effective amount of the pharmacologically acceptable salt of claim 2 to a patient in need thereof.
- 7. A method of treating endotoxic shock, comprising administering an effective amount of the pharmaceutical composition of claim 3 to a patient in need thereof.
- 8. A method of treating endotoxic shock, comprising administering an effective amount of the pharmaceutical composition of claim 4 to a patient in need thereof.
Priority Claims (1)
Number |
Date |
Country |
Kind |
RM93A0468 |
Jul 1993 |
IT |
|
Parent Case Info
This is a Division, of application Ser. No. 08/274,686 filed on Jul. 14, 1994, now U.S. Pat. No. 5,625,085.
US Referenced Citations (10)
Foreign Referenced Citations (1)
Number |
Date |
Country |
442850 |
Aug 1991 |
EP |